Crossject Société Anonyme (EPA:ALCJ)
France · Delayed Price · Currency is EUR 2.415
+0.180 (8.05%)
At close: Nov 10, 2025
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €127.37 million as of November 10, 2025. Its market cap has increased by 43.72% in one year.
Market Cap
127.37M
Enterprise Value
141.31M
Revenue
4.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.42
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 127.37M, an increase of 114.42%. That is a compound annual growth rate of 6.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 127.37M | 21.89% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | 77.73M | 68.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.20B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.44B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.83B |